EUVIMEDEUVIMED entdecken
Open Access

GDF11 and aging biology - controversies resolved and pending

Laura Ben Driss, John Lian, Ryan G Walker, James A Howard, Thomas B Thompson, Lee L Rubin, Amy J Wagers, Richard T Lee

The Journal of Cardiovascular Aging · 19.10.2023 · 3 (4)

DOI: 10.20517/jca.2023.23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Cardiovascular Aging, online erschienen am 19.10.2023. Verfasst von Laura Ben Driss und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIA NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the exogenous administration of GDF11, a TGF-ß superfamily member, was reported to have beneficial effects in some models of human disease, there have been many research studies in GDF11 biology. However, many studies have now confirmed that exogenous administration of GDF11 can improve physiology in disease models, including cardiac fibrosis, experimental stroke, and disordered metabolism. GDF11 is similar to GDF8 (also called Myostatin), differing only by 11 amino acids in their mature signaling domains. These two proteins are now known to be biochemically different both in vitro and in vivo . GDF11 is much more potent than GDF8 and induces more strongly SMAD2 phosphorylation in the myocardium compared to GDF8. GDF8 and GDF11 prodomain are only 52% identical and are cleaved by different Tolloid proteases to liberate the mature signaling domain from inhibition of the prodomain. Here, we review the state of GDF11 biology, highlighting both resolved and remaining controversies.

Schlagwörter

Stichwörter der Autor:innen

GDF11agingbrainheartskeletal musclesystemic factor

Autor:innen und Institutionen

  • Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.
  • Department of Molecular and Cellular Biosciences, University of Cincinnati, Cincinnati, OH 45267, USA.
  • Department of Pharmacology and Systems Physiology, University of Cincinnati, Cincinnati, OH 45267, USA.
  • Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Joslin Diabetes Center, Boston, MA 02115, USA.
  • Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.

Förderung

  • NIGMS NIH HHS
  • NIA NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Driss, L. B., Lian, J., Walker, R. G., Howard, J. A., Thompson, T. B., Rubin, L. L., Wagers, A. J., & Lee, R. T. (2023). GDF11 and aging biology - controversies resolved and pending. The Journal of Cardiovascular Aging, 3(4). https://doi.org/10.20517/jca.2023.23

Vancouver

Driss LB, Lian J, Walker RG, Howard JA, Thompson TB, Rubin LL, et al. GDF11 and aging biology - controversies resolved and pending. The Journal of Cardiovascular Aging. 2023;3(4). doi:10.20517/jca.2023.23

BibTeX
@article{Driss2023,
  author = {Driss, Laura Ben and Lian, John and Walker, Ryan G and Howard, James A and Thompson, Thomas B and Rubin, Lee L and Wagers, Amy J and Lee, Richard T},
  title = {GDF11 and aging biology - controversies resolved and pending},
  journal = {The Journal of Cardiovascular Aging},
  year = {2023},
  volume = {3},
  number = {4},
  doi = {10.20517/jca.2023.23}
}
Kostenlos starten →